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Malondialdehyde and 4-hydroxy-2-hexenal are
formed during dynamic gastrointestinal in vitro
digestion of cod liver oils
Karin Larsson,*†a Cecilia Tullberg,*†a Marie Alminger,a Robert Havenaarb and
Ingrid Undelanda
Marine long-chain polyunsaturated fatty acids (LC n-3 PUFA) are associated with reduced risk for inﬂam-
matory diseases, such as cardiovascular diseases and rheumatoid arthritis. These fatty acids, however, are
rapidly oxidized, generating highly reactive malondialdehyde (MDA), 4-hydroxy-2-hexenal (HHE) and
4-hydroxy-2-nonenal (HNE). These oxidation products may interact with DNA and proteins, thus possibly
leading to impaired cell functions. Little is known about the formation of MDA, HHE and HNE in ﬁsh oil in
the gastrointestinal (GI) tract. In this study, the eﬀect of dynamic in vitro digestion of cod liver oil on the
generation of MDA, HHE and HNE was evaluated using the TNO Gastro-Intestinal Model (tiny-TIM).
Eﬀects of pre-formed oxidation products, pre-emulsiﬁcation of the oil, and addition of oxidants (EDTA
and hemoglobin, Hb) on GI oxidation were evaluated. Formation of aldehydes occurred during GI diges-
tion. However, only emulsiﬁed oil fortiﬁed with 11.5 µM Hb oxidized to a degree that overcame the
dilution induced by gastric secretion, which caused increased aldehyde concentrations in gastric lumen
up to 90 min. The maximum levels of aldehydes generated in this study were 24.5 µM MDA, 1.6 µM HHE
and 0.07 µM HNE. Oils containing diﬀerent amounts of pre-formed lipid oxidation products maintained
the same oxidation ranking order during digestion, even though the relative changes were not directly
proportional. Emulsiﬁcation of the oil had an unclear eﬀect in the gastric phase, but a pro-oxidative eﬀect
in the intestinal phase. In general, higher aldehyde levels were reached in the intestinal lumen than in the
initial meal, demonstrating that GI digestion promotes oxidation. Hence, epithelial cells may be exposed
to elevated amounts of reactive aldehydes for several hours after a meal containing ﬁsh oil.
1 Introduction
Marine food, such as fish and fish oil, is considered to be an
important source of long chain n-3 polyunsaturated fatty acids
(LC n-3 PUFA) in the human diet. LC n-3 PUFA, or omega-3,
have been linked to various positive health eﬀects in the human
body. LC n-3 PUFA, e.g. in the form of eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA), are believed to reduce
the risk of cardiovascular diseases (CVD),1 and have also been
connected with beneficial eﬀects on inflammatory diseases.2
However, PUFA are highly susceptible towards lipid oxidation,
which degrades the oil and generates a cascade of lipid oxidation
products.3 Some of the lipid oxidation products formed are
highly reactive and can continue to interact with the surrounding
molecules, creating protein-, and DNA-adducts, as well as cross-
linkages between proteins.3 The lipid oxidation reaction is gener-
ally undesirable in the food industry, since it not only decreases
the initial nutritional status of the food, e.g. by decreasing the LC
n-3 PUFA content, but also gives rise to various qualitative
changes, such as changes in the odor, color and texture of
food.3,4 In the last 10–15 years, the potential of lipids to be oxi-
dized also during passage through the gastrointestinal (GI) tract
has been increasingly addressed,5,6 and here, the reactivity of the
formed oxidation products is indeed particularly important.
A common marker molecule for the lipid oxidation reaction is
malondialdehyde (MDA). MDA can be derived from a variety of
molecules, but is generally connected with PUFA.7 The impact of
MDA on a biological material has been widely studied,7,8 and the
molecule has been shown to act in both carcinogenic and geno-
toxic routes.7 Other reactive lipid oxidation products that can be
found in fish are 4-hydroxy-trans-2-hexenal (HHE), specifically
derived from LC n-3 PUFA9,10 and 4-hydroxy-trans-2-nonenal
(HNE) coming from LC n-6 PUFA.9,11 The latter could be expected
to develop specifically in farmed fish fed vegetable oils since their†First authors.
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level of LC n-6 PUFA is higher than in wild carnivorous fish.12
When adding tuna oil (10% w/w), containing ∼25% LC n-3 PUFA,
to turkey meat, Tirosh et al.13 found that higher levels of MDA
equivalents were detected (600 µM), compared to when refined
olive oil containing 0.5% n-3 PUFA was added to the turkey meat
(10% w/w; 90 µM MDA equivalents), after 180 min gastric in vitro
digestion. This indicates the potency of marine oils with a high
content of LC n-3 PUFA to oxidize and form MDA.
There are several factors of importance for the onset and
development of the lipid oxidation reaction in the GI tract.
Halliwell et al.14 stated that chemical conditions in the GI
tract, such as the presence of catalyzing agents like hydroper-
oxides, hemoglobin (Hb) and iron ions enhance the risk of
lipid oxidation.14 Kanner and Lapidot5 raised the possibility of
the gastric tract to act as a hub for the lipid oxidation reaction
due e.g. to the low pH and presence of oxygen that could
induce lipid oxidation.5 Since then, several studies have con-
firmed the concerns raised, and it has recently been shown
that the lipid oxidation reaction can take place in the GI tract
during digestion of marine oil.15–19 Larsson et al.15 showed
that lipid oxidation could occur both in the gastric and duo-
denal step during static in vitro digestion of bulk and emulsi-
fied cod liver oil. It was shown that pre-oxidized oil gave rise to
increased formation of lipid oxidation products, and that the
addition of Hb had a catalyzing eﬀect on the lipid oxidation.15
Static in vitro digestion models are easy to use, but not fully rea-
listic since they do not account for the addition of digestive
enzymes and removal of dissolved low molecular weight digestion
products and water from the system, by dialysis and filtration, over
time. Dynamic models fit better to in vivo conditions and hence
should give a better picture of the actual digestion mechanisms.
One of the dynamic in vitro digestion systems commonly used
today is the TNO Gastro-Intestinal Model (TIM), where a gradual
change in pH, addition of enzymes and bile, and removal of
liquid and nutrients over time are included. It has not earlier been
investigated to what extent pre-formed oxidation products, emulsi-
fication and the presence of pro- and antioxidants aﬀect oxidation
of cod liver oil under dynamic in vitro digestion conditions.
In this study, cod liver oil was evaluated for its sensitivity
towards GI lipid oxidation using the TIM system. The eﬀects of
pre-emulsification as well as initial oil quality were investigated
on subsequent GI oxidation. The impact of including Hb, a pro-
oxidant, and EDTA, a chelating agent, in the test meal was
additionally evaluated. Furthermore, we wished to investigate
the influence of endogenous ascorbic acid in the gastric fluid
because of its bifunctional role in lipid oxidation. As oxidation
responses, we determined the concentrations of reactive alde-
hydes (MDA, HHE and HNE), which could give an insight into
the risks for potential toxicological eﬀects from GI oxidation.
2 Materials and methods
2.1 Chemicals
Pepsin (2188 U mg−1) from porcine gastric mucosa, α-amylase
(1333 U mg−1) from Bacillus sp., trypsin from bovine pancreas,
Patent Blue V sodium salt, ethylenediaminetetraacetic acid
(EDTA), disodium salt dihydrate, ascorbic acid, 1,1,3,3-tetra-
ethoxypropane and 2,4-dinitrophenylhydrazine (DNPH) were
purchased from Sigma-Aldrich (Stockholm, Sweden). Brij 35
was obtained from Fisher Scientific (Acros Organics, Västra
Frölunda, Sweden). Lipase F-AP 15 (150 U mg−1) from Rhizopus
oryzae was purchased from Amano Enzyme Inc. (Nagoya,
Japan). Fresh porcine bile was obtained from TNO (Zeist, The
Netherlands). Pancreatin (Pancrex-Vet, Pfizer, Karlsruhe,
Germany) was purified by centrifugation (9000g, 20 min, 4 °C)
before use. Wheat flour bread containing 1% vegetable oil
(0.4% saturated) was bought in a local supermarket.
4-Hydroxy-2-hexenal (HHE) and 4-hydroxy-2-nonenal (HNE)
were purchased from Cayman Chemicals (Michigan, USA). All
other chemicals used were of analytical grade.
2.2 Cod liver oil
Refined cod liver oil without added antioxidants was supplied
by LÝSI hf. (Reykjavík, Iceland). The content of total PUFA in
the oil was 27.5%, the content of n-3 PUFA was 24.4% (8.2%
EPA and 10.5% DHA), and the content of n-6 PUFA was
1.3%.20 In addition, it contained 48% MUFA, and 17.2%
SFA.20 The fatty acid profile of the oil is reported in Jónsdóttir
et al.20 The anisidine value (AV) and the peroxide value (PV) are
both methods commonly used by the oil industry when asses-
sing the quality of fish oil.21 PV detects primary oxidation pro-
ducts, while AV detects secondary oxidation products.22 The AV
of the fresh oil was 8.5 meq kg−1 according to the manufac-
turer, and the PV was 1.3 mmol kg−1 oil when measured in-
house. The oil was used either fresh or after storage in Erlen-
meyer flasks for 6 and 9 days at room temperature to create in
total three diﬀerent levels of pre-formed oxidation products
(Table 1). The two oxidized oils are referred to as “medium ox”
(PV 12.4 mmol kg−1 oil) and “high ox” (PV 20.9 mmol kg−1
oil). All oil samples were then stored at −80 °C until use.
2.3 Test meals
Cod liver oil was thawed in ice-cold water, and for meals con-
taining emulsified oil, an oil-in-water emulsion (20%, w/w)
was freshly prepared by homogenizing (CAT X620, M. Zipperer
GmbH, Germany) the oil with an emulsifier solution (17 mM
Brij 35 in 10 mM phosphate buﬀer, pH 7.0) for 2 min at 24 000
rpm, while being kept on ice-cold water. Test meals were
Table 1 Amount (mean ± SD; n = 3) of pre-formed lipid oxidation pro-
ducts in fresh and oxidized cod liver oil (CO). “Medium ox” oil was stored
6 days at room temperature and “highly ox” oil was stored 9 days at
room temperature
PV (mmol
kg−1 oil)
MDA (µmol
kg−1 oil)
HHE (µmol
kg−1 oil)
HNE (µmol
kg−1 oil)
CO fresh 1.3 ± 0.1 2.8 ± 0.2 1.9 ± 0.1 0.03 ± 0.01
CO medium ox 12.4 ± 0.6 25 ± 1 4.1 ± 0.5 0.06 ± 0.01
CO high ox 20.0 ± 1.8 47 ± 8 5.5 ± 1.2 0.08 ± 0.02
CO, cod liver oil.
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freshly prepared from wheat flour bread, water and 5 g cod
liver oil or oil-in-water emulsion (containing 5 g cod liver oil)
and mixed with 20 mL simulated saliva (containing NaCl 6.2 g
L−1, KCl 2.2 g L−1, CaCl2·2H2O 0.3 g L
−1, amylase 0.007 g per
test meal) according to Table 2. Bread was added as a bulk food
to the test meal to ensure proper gastric emptying when the oil
was given. To evaluate any influence of the bread on the GI oxi-
dation of cod liver oil during digestion, selected samples with
emulsified oil were given without bread (Table 3). To simulate
the gastric residues present in an empty stomach, 5 g of gastric
residue (NaCl 6.1 g L−1, KCl 2.2 g L−1, CaCl2·2H2O 0.3 g L
−1,
10 mM sodium acetic buﬀer pH 5, pepsin 264 mg L−1 and
lipase 248 mg L−1) was added together with the test meal prior
to the experiments. The pH of the intake was adjusted to 6.5
with 1 M NaHCO3. Blank experiments without any cod liver oil,
but with or without bread, were included to determine the back-
ground level of oxidation products in the model. In test meals
including EDTA (7.5 mg) or Hb (11.5 µmol L−1 emulsion), the
oxidants were added just prior to feeding.
2.4 Hemolysate preparation and hemoglobin quantification
Blood was obtained from freshly slaughtered farmed Atlantic
cod (Gadus morhua) and purified according to Fyhn et al.23 After
conversion to the carbon monoxide form, the Hb concentration
was quantified against a bovine Hb standard.24 Both methods
were modified as described by Richards and Hultin.25
2.5 Dynamic in vitro digestion
Computer-controlled dynamic digestions were performed in
the two-compartmental digestion system called tiny-TIM (TNO,
Zeist, Netherlands),26 according to the detailed digestion set-
tings described in Larsson et al.17 Tiny-TIM simulates the
gastric phase and the average digestive actions in the small
intestine, including absorption. It is a slightly simplified
version of the original TIM-1 system, simulating four succes-
sive compartments (stomach, duodenum, jejunum and
ileum).27 Secretion of hydrochloric acid and simulated gastric
juice (electrolytes, pepsin and lipase) to the stomach (1 mL
min−1), as well as secretion of bicarbonate, pancreatic juice
(pancreatin) and bile to the small intestine (1 mL min−1) is
regulated and programmed to simulate human adult digestion
of a semi-solid food. An intestinal residue containing 35 mL
bile, 35 mL pancreatin and 70 mg trypsin was added prior to
the start of the ingestion experiment. To evaluate the eﬀect of
endogenous concentration of ascorbic acid in gastric juice on
GI oxidation, one digestion was made with 85 µM ascorbic
acid in the gastric secretion. Each digestion was run for at
least 180 min (prolonged digestion for 300 min). Sampling of
gastric and intestinal lumen (3 mL) was done every 30 min,
and sample aliquots were stored at −80 °C until analysis for
lipid oxidation products.
The dilution of the test meals during dynamic digestion,
due to continuous secretion of digestive compounds and
removal of compounds via intestinal absorption and sampling,
was verified in two experiments with the coloring agent Patent
Blue V dissolved in an electrolyte. At every sampling point the
change in concentration was followed by absorbance readings
at 638 nm.
2.6 Analysis of MDA, HHE and HNE
The amounts of MDA, HHE and HNE were determined by
LC/APCI-MS in gastric and intestinal lumen samples and in
bulk oils after derivatization with DNPH according to the
method described by Tullberg et al.16 Briefly, 500 µL digesta
was mixed with 20 µL BHT (0.1 g mL−1 in MeOH), 40 µL EDTA
(0.02 M) and 500 µL 0.25 M HCl, vortexed and incubated for
5 min. For bulk oils, 50 mg oil was vortexed with 200 µL water
and the additions of EDTA, BHT and HCl were downscaled by
a factor of two. Precipitated proteins were separated by cen-
trifugation (16 000g for 2 min). Derivatization of aldehydes was
performed by mixing 400 µL supernatant with 25 µL DNPH
(2 mg mL−1 in MeOH) and incubated for 1 h at room tempera-
ture. Derivatives were extracted twice with 500 µL dichloro-
methane (16 000g for 2 min at 20 °C) and pooled extracts were
evaporated under a stream of N2 gas and then dissolved in
MeOH before separation and detection by LC/APCI-MS.
Quantification of aldehydes was made against external stan-
dard curves of MDA, HHE and HNE treated in the same way as
the samples. The limit of quantification is a signal-to-noise
ratio of 10, which corresponds to 40 nM MDA, 8 nM HHE and
4 nM HNE in the external standards. All samples reported
were above the limit of quantification. Since no significant
diﬀerences were seen among sample types, or over time from
the detection of HNE, data from this analysis is only briefly
discussed in the text.
Table 2 Composition of 150 g of each test meal (referred to as intake)
digested in the dynamic GI model
Saliva
(g)
Bread
(g)
Water
(g)
Oil/
emulsion (g)
Cod liver oil (bread) 20 20 105 5
Cod liver oil emulsion
(bread/no bread)
20 20/0 85/105 25
Blank (bread/no bread) 20 20/0 110/130 0
Table 3 Overview of digestion experiments with each test meal in the
dynamic GI model with speciﬁcation of the number of replicates with
and without the addition of wheat ﬂour bread
Test meal
Digestion
exp.
With
bread
Without
bread
Blank 3 2 1
Oil fresh 2 2
Oil medium ox 2 2
Oil medium ox + asc 1 1
Oil high ox 2 2
Emulsion fresh 4 2 2
Emulsion fresh + Hb 1 1
Emulsion high ox 2 2
Emulsion high ox + EDTA 1 1
asc, ascorbic acid (85 µM in gastric secretion, 1 mL min−1).
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2.7 Calculations and statistics
The relative aldehyde concentration for each time point was
calculated from the mean aldehyde concentration of the test
meal at that point divided by the calculated remaining aldehyde
concentration of the intake (see equation below). The back-
ground level provided by digested blanks was subtracted from
the intestinal data, to calculate the true GI formation of oxi-
dation products. The relative change is shown between
0–120 min in the gastric lumen. Thereafter the uncertainties of
the relative values increased, due to large dilution of the intake
together with the remaining small gastric digesta volume.
Relative concentrationt¼i ¼ AbsðPatent BlueÞt¼0AbsðPatent BlueÞt¼i
 cðtestmealÞt¼i
cðtestmealÞt¼0
In general, two to four replicate digestion experiments of
each test meal were made; each digestion is here referred to as
“n”, i.e. n = 2–4. To screen the eﬀect of selected oxidants, EDTA
and Hb, and the eﬀect of ascorbic acid in gastric juice, only
single digestion experiments were carried out. The amount of
lipid oxidation products in digests at each time point was
determined by one analytical replicate (here referred to as “a”,
i.e. a = 1), except for in the case of the intake, then a = 2–4.
Results are shown as mean values and error bars represent
standard deviation where n > 2, and (max − min)/2 where n =
2, and concentrations presented as µM of each aldehyde in the
digesta. Statistical diﬀerences between two groups were deter-
mined by Student’s t-test (IBM SPSS Statistics 19, IBM Corp.,
NY, USA). A significance level of p < 0.05 was used.
3 Results and discussion
3.1 Properties of the dynamic gastrointestinal in vitro model
Our aim in this study was to determine what levels of lipid oxi-
dation products can be formed in the gastric and the intestinal
compartments during digestion of cod liver oil using a
dynamic in vitro model (tiny-TIM). Therefore, the concen-
tration of aldehydes in the gastric and in the intestinal lumen is
reported as µM in the digests over time. In order to evaluate to
what extent the fish oil gets oxidized under these conditions, it
is necessary to understand the dilution eﬀect of the dynamic
system. Without any formation or degradation, the initial intake
concentration will change over time, according to Fig. 1. A
linear decrease is observed in the gastric phase up to 150 min,
and approximately 50% of the initial intake concentration
remains at 90 min of digestion. At the same time, a peak of
35% is reached at 90 min after intake in the intestinal lumen.
3.2 Eﬀect of emulsification on MDA and HHE formation
The eﬀect of pre-emulsification of the cod liver oil on the for-
mation of lipid oxidation products during subsequent
dynamic digestion was evaluated in both fresh and highly oxi-
dized cod liver oil. After the emulsification treatment, the
initial MDA and HHE levels of emulsion made of oxidized cod
liver oil were lower compared to bulk oxidized oil (Fig. 2). In
agreement with this, lower aldehyde concentrations were gen-
erated by the emulsified oxidized oil during the entire gastric
digestion. However, for MDA, this diﬀerence disappeared in the
intestinal phase, and in fact, significantly higher (p < 0.05) HHE
levels were formed by the emulsified oxidized oil than by bulk
oil at 60–180 min of digestion. Emulsification of fresh oil had
no apparent impact on the absolute aldehyde values. Similar to
the oxidized oil, lower concentrations of MDA were seen in the
gastric digesta of emulsified fresh oil compared to bulk oil, but
no diﬀerence in intestinal digesta was observed. Again, emulsi-
fied fresh oil caused elevated HHE levels (∼2-fold) compared to
bulk oil during intestinal digestion. In our earlier study,17 a pro-
oxidative eﬀect of emulsification of isolated herring oil on MDA
and HHE was shown in both the gastric and intestinal phase
using the same emulsifier and digestion system.
It has often been reported that a low pH increases the lipid
oxidation in emulsions,28,29 however, in a study by Mei et al.30
it was shown that the susceptibility towards lipid oxidation of
an emulsion stabilized by Brij 35 did not change in the pH
range 3–7, when measuring TBARS and peroxide formation.
The same emulsifier was used in our study, and therefore it is
not surprising that the emulsions were fairly stable from an
oxidative perspective, also at the low pH of the gastric phase.
Emulsions are frequently reported to be more susceptible
towards lipid oxidation than their corresponding bulk oil,31,32
however, this is believed to mainly be caused by the harsh
mechanical treatment during the emulsification process in the
industry. The results from our study show that the emulsifier
used had a somewhat protective eﬀect in the gastric lumen.
This is in line with the diﬀerent initial aldehyde levels in the
emulsion and the bulk oil. A slightly lower formation of MDA
and HHE was observed in the emulsified oxidized oil com-
pared to the bulk oxidized oil. Depending on several factors,
such as pH, emulsifier, and droplet size distribution, an emul-
sion can be more or less susceptible to lipid oxidation com-
pared to its corresponding bulk oil.31 Also the role of the
concentration and structure of the emulsifier for the oxidative
Fig. 1 Concentration of Patent Blue V marker in the gastric and the intes-
tinal compartments, expressed as percent of intake, during dynamic in
vitro digestion in tiny-TIM. Values are mean ± (max −min)/2; n = 2, a = 2.
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stability of the emulsion was pointed out by Kargar et al.,33 as
well as by Nielsen et al.34 An emulsifier can act as a protective
barrier, and the charge, permeability and thickness of the
interface can aﬀect the diﬀusion of both pro- and antioxidants
over the interfacial layer of the emulsion droplet.28 It has
additionally been reported that pro-oxidants can be trapped
within micelles formed by emulsifier in excess,35 which could
protect the oil in the emulsion droplet.
The observed eﬀect of emulsification in the intestinal
phase could be due to the change in pH and the addition of
bile salts, which could lead to a shift in emulsifier distribution
of the emulsion droplet surface. The unequivocal protective
eﬀect of Brij 35 in the gastric phase might also be lost in the
intestinal phase due to the pH change, a shift in the compo-
sition of the aqueous phase and the competition to the droplet
interface from other emulsifiers.
3.3 Eﬀect of pre-formed oxidation products
Bulk oil with diﬀerent amounts of pre-formed oxidation pro-
ducts developed diﬀerent degrees of oxidation during diges-
tion. Gastric digests of fresh oil showed increased MDA levels
already at 30 min of digestion, and developed the highest rela-
tive increase in MDA (5-fold) at 90 min compared to digests of
medium and highly oxidized oil, which generated a 2-fold and
1.7-fold increase, respectively at this point (Fig. 3A and B). The
MDA levels detected were however still significantly higher (p
< 0.05) in the medium and highly oxidized oil compared to the
fresh oil at 60–120 min of digestion. The highly oxidized oil
gave also rise to significantly higher MDA levels compared to
the medium oxidized oil at the same time interval. The for-
mation of HHE was more moderate and independent of the
initial oxidation level of the oil. The relative increase was in
the range of 1.3 to 1.6 at 90 min of gastric digestion. Also the
emulsion made of fresh oil led to a raised relative change in
MDA (1.9-fold) during the gastric phase at 90 min. MDA levels
in the emulsion made of highly oxidized oil did not change.
HHE increased 1.3-fold in digests of both emulsions. A drop in
the relative change of HHE was seen at prolonged digestion,
indicating that the dilution eﬀect became predominant. When
looking at the absolute levels of HHE detected in the gastric
lumen, significantly higher levels (p < 0.05) were detected
when digesting both the highly and medium oxidized oil com-
pared to the fresh oil at 60–120 min of digestion.
Relative changes during the intestinal digestion related to
diﬀerent initial oil quality were in agreement with the pattern
from the gastric digestion. Higher relative changes in MDA
and HHE of fresh oil (both emulsified and non-emulsified)
were seen compared to its corresponding oxidized oil (Fig. 3C
Fig. 2 Formation of MDA and HHE in gastric (A and B) and intestinal lumen (C and D) during dynamic in vitro digestion of cod liver oil. Values are
mean ± SD (n > 2) or (max −min)/2 (n = 2).
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and D). The results thus indicate that there is not a strict pro-
portional formation of MDA and HHE based on the initial
amount of oxidation products of the oil during dynamic
in vitro digestion of cod liver oil. However, because of the rela-
tively large diﬀerences in pre-formed oxidation products in the
oils, the highest aldehyde concentrations in the gastric and
intestinal lumen were in general obtained by the initially more
oxidized oils (Fig. 2). In the intestinal lumen, the levels of MDA
and HHE became significantly higher (p < 0.05) with the highly
oxidized oil compared to digestion with the less oxidized oil, at
60–120 min of digestion. The aldehyde levels detected in the
intestinal lumen with the fresh oil and the medium oxidized oil
were however not significantly diﬀerent any more at this time
interval (MDA p = 0.55, HHE p = 0.50). In the case of low GI oxi-
dation, as seen for HHE, the initial proportional diﬀerences will
remain. Despite similar or diﬀerent relative changes in aldehyde
concentration, the actual concentration of reactive aldehydes to
which the GI tract is exposed is crucial.
3.4 Influence of hemoglobin on gastrointestinal oxidation
Hb is one of the most pro-oxidative endogenous compounds
in fish, therefore the impact of adding cod Hb to emulsified
fresh cod liver oil (11.5 µmol L−1 emulsion) on GI oxidation
was evaluated (Fig. 4). The addition of Hb to the emulsified oil
had a strong immediate eﬀect on the initial MDA and HHE
levels in the test meal, which were about 17-fold and 3-fold
higher, respectively, compared to the control without Hb.
During gastric digestion in the presence of Hb, both the MDA
and the HHE levels peaked at 90 min (25 µM and 0.5 µM,
respectively), and the levels determined were 70- and 12-fold
higher compared to fresh emulsions, and the levels of both
MDA and HHE detected at 60–120 min were significantly
higher (p < 0.05) compared to the control. When looking at
the relative changes, emulsion with Hb gave rise to the highest
levels of both MDA and HHE in the gastric tract, and HHE in
the intestinal tract, compared to all test meals (Fig. 4 and 5).
A pro-oxidative eﬀect of 20 µM met-myoglobin was seen
during in vitro digestion of emulsions made of tuna oil,
soybean oil and linoleic acid.5,18 A low pH has been shown to
promote lipid oxidation in fish muscle, which has been pro-
posed to be due to the oxidation of Hb to metHb, followed by
subsequent loss of the hemin group.36 A mild denaturation of
the heme protein at acidic pH could also increase the exposure
of the heme group, thereby promoting lipid oxidation.37 One
of the suggested mechanisms for the pro-oxidative eﬀect of
heme iron is decomposition of hydroperoxides. Kumar Sau
et al.38 also discussed that a change in the heme pocket could
lead to binding of the iron to a distal histidine, which implies
Fig. 3 Relative change in concentration of MDA and HHE during gastric (A and B) and intestinal digestion (C and D) of emulsiﬁed and non-emul-
siﬁed cod liver oil with diﬀerent amounts of pre-formed lipid oxidation products.
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that metHb or oxyHb could be changed into low spin Fe3+ hemi-
chromes. This transformation could lead to the generation of
superoxide radicals.38 As shown in liposomes, the autooxidation
of Hb generating the more pro-oxidative metHb form can more-
over be stimulated by lipid hydroperoxides and aldehydes.39
3.5 Influence of ascorbic acid in simulated gastric juice
Ascorbic acid is endogenously secreted in the gastric juice, and
studies on healthy human volunteers have previously reported
levels of 89 and 87 µM ascorbic acid.40,41 This molecule can
act both as a pro- and as an antioxidant depending on the sur-
rounding matrix and its concentration.42 Ascorbic acid can
promote lipid oxidation in the presence of trace metal ions;
this is due to its reducing ability creating e.g. ferrous ions
which can participate in the Fenton reaction.42 Ascorbic acid
can, however, also regenerate tocopherols and act as a reactive
oxygen scavenger.43 To our knowledge, it has not earlier been
shown whether ascorbic acid, as a constituent in human
gastric juice, would work as a pro- or an antioxidant during in
vitro digestion. Ascorbic acid was added to the gastric residue
prior to the experiment, which was then added to the sample
at the point of intake, giving a starting concentration of
2.7 µM ascorbic acid. The gastric juice also contained 85 µM
of ascorbic acid and the secretion was set at 1 mL min−1. The
inclusion of ascorbic acid had a clear pro-oxidative eﬀect on
the formation of MDA in highly oxidized cod liver oil during
digestion (Fig. 4). Approximately 3-fold higher relative MDA
concentrations were formed in the gastric and in the intestinal
compartment when ascorbic acid was present (Fig. 5), and the
levels of MDA detected at 60–120 min of digestion in both the
gastric and the intestinal step were significantly higher (p <
0.05) compared to the control. Ascorbic acid, however, had no
eﬀect on the gastric formation of HHE, but generated signifi-
cantly higher HHE concentrations in the intestinal step at
60–120 min of digestion.
The pro-oxidative eﬀect of ascorbic acid could be due to its
relatively low concentration in combination with the presence
of trace metal ions in the oil, 0.13 µM Cu and 0.7 µM Fe at
intake. Decker et al.44 described that ascorbate levels found in
fish muscle (60–100 µM) are eﬀective in activating ionic iron to
stimulate oxidation. Studies from beef and fish muscle have
reported a shift in the activity of ascorbic acid from anti- to
pro-oxidative at 2.8 mM;45,46 in purified white fish muscle with
lower Fe-levels, the pro-oxidative eﬀect was seen already to be
<280 µM.45 Ascorbic acid turned from an antioxidant into a
pro-oxidant at 8 mM in phosphatidylcholine liposomes forti-
Fig. 4 Eﬀect of Hb addition to (11.5 µM) or the inclusion of 85 µM ascorbic acid in gastric secretion on the formation of MDA and HHE in gastric
(A and B) and intestinal lumen (C and D) during dynamic in vitro digestion of cod liver oil. Values are mean ± SD (n > 2) or (max −min)/2 (n = 2).
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fied with 9 µmol Fe kg−1.47 Ascorbate in combination with
copper or iron ions has also been shown to generate OH• in
the gastric compartment of rats.48,49 Additionally, when
ascorbic acid was included at 100 µM during static gastric in
vitro digestion of a herring oil emulsion, Kristinova et al.50 saw
a pro-oxidative eﬀect.
3.6 Eﬀect of EDTA on GI oxidation
EDTA has a metal chelating activity in oil-in-water emulsions,28
however, the eﬀect of EDTA appears to depend on the concen-
tration and type of oil being emulsified.51 In this study, 50 µg
EDTA g−1 intake was tested together with highly oxidized oil
based on the earlier findings that 10 and 50 µg EDTA g−1 fish
oil enriched dressing strongly reduced lipid oxidation products
during storage at room temperature.52 EDTA had a slightly
decreasing eﬀect on MDA and HHE formation in the gastric
step, with a decrease of MDA (30%) and HHE (10%) formation
at 90 min, compared to the control with no added EDTA (data
not shown). This eﬀect appeared to be lost in the intestinal
phase, where we only saw a slight decrease in MDA (1%) and
an increase in HHE (70%) formation. However, due to the low
sample number with EDTA, our results can only be considered
as trends.
Frankel et al.32 showed that EDTA only worked as an anti-
oxidant in mackerel oil-in-water emulsions when added in
higher concentrations than that of iron. In some food systems,
the EDTA : iron ratio of 3.4–4.5 : 1 did not have any eﬀect.53 In
our experiments, the EDTA : iron ratio in the oil at the point of
intake was ∼200 : 1. EDTA concentrations above 2.5 µM signifi-
cantly decreased lipid oxidation in fish oil emulsions using
the same emulsifier as was used here (Brij 35).54 Also during
gastric digestion of herring oil, EDTA (0.7 µM) was found to
reduce lipid oxidation by more than 50%.19 The EDTA concen-
tration used in our study (0.13 mM in the test meals) should
be suﬃcient to get an antioxidative eﬀect of GI oxidation,
however this was not the case. An explanation could be the
fact that we used highly oxidized oil, containing pre-formed
radicals, and thus were less dependent on the presence of iron
ions for de novo radical formation.
3.7 Which concentrations of MDA, HHE and HNE are
formed during digestion?
The overall highest MDA and HHE concentrations reached
during dynamic digestion of cod liver oil in this study were
determined in Hb enriched emulsion, 24.5 and 0.5 µM,
respectively, in the gastric phase at 90 min. An almost equally
high peak MDA concentration was determined in the intestinal
Fig. 5 Relative changes in concentration of MDA and HHE during gastric (A and B) and intestinal digestion (C and D).
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phase at 150 min (20.5 µM). However, the HHE concentration
reached was extensively higher in the intestinal phase (1.6 µM)
than the gastric phase (0.5 µM). Among the oils without any
added pro-oxidants, the MDA and HHE levels did generally not
exceed their intake concentrations in the gastric phase. In con-
trast, most samples generated higher MDA and HHE concen-
trations in the intestinal phase with maxima at 9.4 and 1.0 µM,
respectively. When digesting fresh bulk oil, the highest MDA and
HHE levels reached were 3.8 µM and 0.15 µM, respectively. The
relative formation of MDA and HHE was rather stable in the
gastric tract (Fig. 3 and 5), the exception being fresh bulk oil,
which increased already after 30 min. The high levels of MDA
and HHE detected in the intestinal phase demonstrated a contin-
ued oxidation. The maximum levels reached in cod liver oil emul-
sion fortified by Hb were similar to the levels earlier obtained
during dynamic digestion of herring mince: 27 µM MDA and
0.9 µM HHE in the gastric phase at 90 min, and 23 µM MDA and
0.5 µM HHE in the intestinal phase at 150 min.17
HNE levels, detected in the gastric and the intestinal
phases did not exceed 0.07 µM in any sample, and thus were
very low compared to MDA and HHE. This is in accordance
with the low LC n-6 PUFA content of the cod liver oil. During
gastric digestion of fresh oil, the relative increase of HNE
showed a similar formation pattern to MDA, increasing 3.5
and 5-fold, respectively, at 90 min.
In static digestions of beef, 28 and 0.52 µM MDA and HNE
were found at the end of the duodenal phase.55 Similar levels
were found after approximate recalculations by the authors,
from µmol kg−1 product to µM in the digesta, detected by Step-
peler et al.56 in the duodenal phase during static in vitro diges-
tion of salmon; 20, 0.5, 0.1 µM MDA equivalents, HHE and
HNE. Further, Kenmogne-Domguia et al.18 found 240 µM
MDA, 7.2 µM HHE, 1.2 µM HNE after static in vitro digestion
of tuna : sunflower oil (50% w/w, containing 17.5% n-3 PUFA
and 10% n-6 PUFA) at the end of the intestinal phase. In our
own previous study57 22 µM total MDA and 0.26 µM HHE was
found after static digestion of fresh cod liver oil. Since there are
no available other studies reporting MDA, HHE and HNE data
from dynamic in vitro digestion of marine lipids, these are the
most related data we can access. As outlined above, the present
study revealed that fresh cod liver oil generated 3.8 µM MDA,
0.15 µM HHE and 0.02 µM HNE after 180 min dynamic diges-
tion. Although static models are very useful to compare e.g.
diﬀerent treatments, meals or oil types, it is however obvious
that absolute aldehyde levels could be diﬀerent from that in
dynamic models due to lack of continuous secretion and
product removal. This is an important feature to consider, and
to establish further, if data could be used to understand poten-
tial physiological eﬀects from aldehyde-containing digests.
4 Conclusion
The results presented in this study shows that reactive alde-
hydes were formed during dynamic in vitro digestion of cod
liver oil, using the tiny-TIM system. The presence of cod Hb
and pre-formed oxidation products largely elevated the alde-
hyde levels reached. Oils containing diﬀerent amounts of pre-
formed lipid oxidation products, maintained the same oxi-
dation ranking order in the gastric and in the intestinal phase,
even though the relative changes were not directly proportional
to the initial oxidation status. This implies that it is important
to prevent lipid oxidation prior to ingestion in order to mini-
mize subsequent aldehyde formation in the GI tract. For most
test meals, the highest aldehyde concentrations were formed
in the intestinal phase, and the elevated levels lasted for
several hours. The outcome indicates the importance of con-
sidering the whole food chain: processing, product design,
storage, and meal composition to avoid post-prandial oxidative
changes, and thereby maximizing the desired bioactive eﬀects
from the LC n-3 PUFA.
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